Amicus Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 185.2M | 169.1M | 154.7M | 125.2M | 149.7M | 141.5M | 126.7M | 110.4M |
| Cost of Goods Sold | 28.4M | 21.3M | 15.2M | 11.7M | 14.8M | 13.3M | 11.3M | 13.6M |
| Gross Profit | 156.8M | 147.7M | 139.5M | 113.6M | 134.9M | 128.2M | 115.4M | 96.8M |
| R&D Expenses | 23.7M | 23.4M | 60.8M | 27.8M | 30.2M | 26.2M | 24.7M | 28.3M |
| Operating Expenses | 140.8M | 113.5M | 148.9M | 121.5M | 118.9M | 106.6M | 100.4M | 124.6M |
| Operating Income | 15.9M | 34.3M | -9.5M | -8.0M | 16.0M | 21.7M | 15.0M | -27.7M |
| Other Income / Gains | -12.8M | 5K | -9.7M | -10.1M | -8.0M | -14.9M | -14.9M | -15.9M |
| Net Income | 1.7M | 17.3M | -24.4M | -21.7M | 14.7M | -6.7M | -15.7M | -48.4M |
| EPS (Diluted) | 0.005 | 0.056 | -0.08 | -0.07 | 0.049 | -0.02 | -0.05 | -0.16 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.846 | 0.874 | 0.902 | 0.907 | 0.901 | 0.906 | 0.911 | 0.877 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 117.1M | 90.0M | 84.5M | 91.8M | 86.7M | 75.1M | 73.6M | 88.0M |
| Other Expenses | 0 | 0 | 3.6M | 1.8M | 2.0M | 5.3M | 2.2M | 8.2M |
| Cost And Expenses | 169.3M | 134.8M | 164.2M | 133.2M | 133.7M | 119.9M | 111.7M | 138.1M |
| Interest Income | 833K | 829K | 843K | 812K | 1.4M | 1.1M | 1.4M | 1.5M |
| Interest Expense | 11.4M | 11.7M | 11.6M | 11.5M | 12.0M | 12.7M | 12.5M | 12.4M |
| Depreciation And Amortization | 1.9M | 1.9M | 1.9M | 1.8M | 2.0M | 2.2M | 2.2M | 2.2M |
| Ebitda | 16.5M | 47.9M | -5.8M | -4.8M | 21.9M | 21.6M | 14.8M | -29.0M |
| Ebitdaratio | 0.089 | 0.283 | -0.037 | -0.038 | 0.147 | 0.153 | 0.117 | -0.263 |
| Operating Income Ratio | 0.086 | 0.203 | -0.061 | -0.063 | 0.107 | 0.153 | 0.118 | -0.251 |
| Income Before Tax | 3.1M | 34.3M | -19.2M | -18.0M | 7.9M | 6.8M | 108K | -43.6M |
| Income Before Tax Ratio | 0.017 | 0.203 | -0.124 | -0.144 | 0.053 | 0.048 | 0.001 | -0.395 |
| Income Tax Expense | 1.5M | 17.0M | 5.2M | 3.6M | -6.8M | 13.5M | 15.8M | 4.8M |
| Net Income Ratio | 0.009 | 0.102 | -0.158 | -0.173 | 0.098 | -0.048 | -0.124 | -0.439 |
| Epsdiluted | 0.005 | 0.056 | -0.08 | -0.07 | 0.049 | -0.02 | -0.05 | -0.16 |
| Weighted Average Shs Out | 309.0M | 308.5M | 308.3M | 307.7M | 299.0M | 304.7M | 303.8M | 302.9M |
| Weighted Average Shs Out Dil | 314.4M | 310.4M | 308.3M | 307.7M | 299.0M | 304.7M | 303.8M | 302.9M |